Health-related quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is not different than cytoreductive surgery alone in primary ovarian cancer patients (009)
- Resource Type
- Abstract
- Source
- In
Gynecologic Oncology September 2023 176 Supplement 1:S8-S8 - Subject
- Language
- ISSN
- 0090-8258